Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 5, pp. 416-422
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 533
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Manoj K. Jaiswal
Medicinal Research Reviews (2018) Vol. 39, Iss. 2, pp. 733-748
Closed Access | Times Cited: 373
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 226
Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases
Jenny L. Carey, Lin Guo
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 100
Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects
Paola Ruffo, Bryan J. Traynor, F. L. Conforti
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access | Times Cited: 2
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Giancarlo Logroscino, Marco Piccininni, Benôıt Marin, et al.
The Lancet Neurology (2018) Vol. 17, Iss. 12, pp. 1083-1097
Open Access | Times Cited: 145
Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic
Benjamin G. Trist, James B. Hilton, Dominic J. Hare, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 17, pp. 9215-9246
Open Access | Times Cited: 138
Riluzole, disease stage and survival in ALS
Thanuja Dharmadasa, Matthew C. Kiernan
The Lancet Neurology (2018) Vol. 17, Iss. 5, pp. 385-386
Open Access | Times Cited: 124
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis
Jinsy Andrews, Carlayne E. Jackson, Terry Heiman‐Patterson, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2020) Vol. 21, Iss. 7-8, pp. 509-518
Open Access | Times Cited: 116
Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
Vincent Grollemund, Pierre‐François Pradat, Giorgia Querin, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis
Jonu Pradhan, Peter G. Noakes, Mark C. Bellingham
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 111
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 8, pp. 724-735
Closed Access | Times Cited: 99
The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
Qianqian Zeng, Jie Shen, Kangzhi Chen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 95
Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2616-2616
Open Access | Times Cited: 91
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
Julian Gold, Dominic B. Rowe, Matthew C. Kiernan, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 20, Iss. 7-8, pp. 595-604
Open Access | Times Cited: 80
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Namita Goyal, James Berry, Anthony J. Windebank, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 2, pp. 156-166
Open Access | Times Cited: 78
Canadian best practice recommendations for the management of amyotrophic lateral sclerosis
Christen Shoesmith, Agessandro Abrahão, Tim J Benstead, et al.
Canadian Medical Association Journal (2020) Vol. 192, Iss. 46, pp. E1453-E1468
Open Access | Times Cited: 73
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
Jiantao Zhao, Xuemei Wang, Zijun Huo, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2049-2049
Open Access | Times Cited: 63
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells
Caterina Peggion, Valeria Scalcon, Maria Lina Massimino, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 614-614
Open Access | Times Cited: 50
New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Chemistry of Pentafluorosulfanyl Derivatives and Related Analogs: From Synthesis to Applications
Reza Kordnezhadian, Bing‐Yu Li, Armir Zogu, et al.
Chemistry - A European Journal (2022) Vol. 28, Iss. 60
Open Access | Times Cited: 47
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
Ryosuke Oki, Yuishin Izumi, Koji Fujita, et al.
JAMA Neurology (2022) Vol. 79, Iss. 6, pp. 575-575
Open Access | Times Cited: 44
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes
Federica Raguseo, Yiran Wang, Jessica Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top